Skip to content

Clinical trials

Neurodegenerative Diseases trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Country / region: Switzerland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20161
20171
20191
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis2
Amoneta Diagnostics SAS1
Insel Gruppe AG, University Hospital Bern1
Luzerner Kantonsspital1
Novartis Pharmaceuticals1
University Medical Center Goettingen1
University of Bern1
University of Zurich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases9
Central Nervous System Diseases5
Alzheimer Disease4
Parkinson Disease3
Basal Ganglia Diseases2
Movement Disorders2
Amyotrophic Lateral Sclerosis1
Brain Diseases1
Dementia1
Frontotemporal Dementia1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.